Skip to main content
. 2017 Sep 12;31(11):2398–2406. doi: 10.1038/leu.2017.253

Figure 3.

Figure 3

Overall survival by disease risk (Euro-score). (a) Low, (b) intermediate, (c) high. AraC, cytarabine; IFN, interferon-α OS, overall survival; IM, imatinib.